Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 1

Conditions

Head and Neck Neoplasms 7Hot Flashes 6Breast Neoplasms 6Pain, Postoperative 4Prostatic Neoplasms 3Pain 3Vomiting 2Squamous Cell Carcinoma of Head and Neck 2Oropharyngeal Neoplasms 2Neuralgia 2Neoplasms 2Nausea 2Mucositis 2Anxiety Disorders 2Agnosia 2Acute Pain 2Urinary Bladder Neoplasms 1Stomatitis 1Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 1Rectal Neoplasms 1Psychotic Disorders 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Peripheral Nervous System Diseases 1Neurotoxicity Syndromes 1Myalgia 1Lymphoma, Follicular 1Lung Neoplasms 1Laryngeal Diseases 1Ileus 1Glioblastoma 1

Interventions

pembrolizumab 180Gemcitabine 168Paclitaxel 150Carboplatin 134Bevacizumab 126Cisplatin 113Docetaxel 112Cyclophosphamide 109Exercise 97Nivolumab 92Fluorouracil 88Capecitabine 85Dexamethasone 81Irinotecan 74Radiotherapy 68Oxaliplatin 68Pemetrexed 66Standard of Care 64Leucovorin 63Cetuximab 59Sorafenib 53Erlotinib Hydrochloride 53Drug Therapy 53Blood Specimen Collection 52Doxorubicin 50trametinib 47atezolizumab 47Ipilimumab 47Albumin-Bound Paclitaxel 44130-nm albumin-bound paclitaxel 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Neoplasms × Gabapentin × Clear all
NCT05510856 2024-11-22

Comparative Clinical Study Evaluating the Possible Efficacy of Duloxetine, Gabapentin and Lacosamide on Oxaliplatin-Induced Peripheral Neuropathy in Cancer Patients

Tanta University

Phase 4 Completed
93 enrolled

Neoplasms, Peripheral Nervous System Diseases

NCT03682367 2021-07-09

Perioperative Analgesia Using Gabapentin in Head and Neck Cancer Surgery

University of California, Davis

Phase 3 Terminated
8 enrolled 6 charts
Head & Neck

Head and Neck Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡